Biohit Oyj: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Biohit Oyj Updates on Establishment of Chinese Joint Venture
Biohit Oyj announced that the official Certificate of Approval required for the establishment of a Joint Venture with foreign investment in the People’s Republic of China has been received for the Joint Venture formed between Anhui Wisdom-win Investment Co, Ltd. and Biohit Oyj. The Joint Venture has been registered as Biohit Healthcare (Hefei) Co., Ltd., located in the city of Hefei in Anhui province, China. The regulatory approvals regarding the start of the production are pending and are expected to be finalized during 2014.
Latest Developments forBiohit Oyj
Latest Key Developments inPharmaceuticals
- R-Tech Ueno completes Phase I Single-Dose Clinical Trial for the novel VAP-1 Inhibitor RTU-1096
- Faes Farma says bilastine is ready for registration process in Japan
- PT Taisho Pharmaceutical Indonesia Tbk announces FY 2014 cash dividend; appoints new president commissioner
- Shanghai Kai Kai Industry announces resignation of chairman
- Share this
- Digg this